Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00400478
Status:
COMPLETED
Last Update Posted:
2016-05-26
First Post:
2006-11-16
Brief Title:
A Multicentre Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma NHL-13
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization Data
Organization:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Class:
OTHER
Study ID:
NHL-13 ML18223
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |